Perigon Wealth Management, LLC Crispr Therapeutics Ag Transaction History

Perigon Wealth Management, LLC

$3.97 Billion
Q4 2024

A detailed history of Perigon Wealth Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 16,757 shares of CRSP stock, worth $696,923. This represents 0.02% of its overall portfolio holdings.

Number of Shares

16,757

Previous 15,040 11.42%

Holding current value

$696,923

Previous $706,000 6.66%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$38.65 - $55.15 $66,362 - $94,692	1,717 Added 11.42%	16,757 $659,000
Q3 2024 Oct 16, 2024	BUY	$44.62 - $62.75 $17,312 - $24,347	388 Added 2.65%	15,040 $706,000
Q2 2024 Aug 02, 2024	SELL	$51.17 - $68.18 $4,554 - $6,068	-89 Reduced 0.6%	14,652 $791,000
Q1 2024 Apr 29, 2024	SELL	$60.67 - $89.12 $10,738 - $15,774	-177 Reduced 1.19%	14,741 $1 Million
Q4 2023 Jan 29, 2024	BUY	$38.62 - $72.18 $23,519 - $43,957	609 Added 4.26%	14,918 $933,000
Q3 2023 Oct 30, 2023	BUY	$45.39 - $59.0 $132,765 - $172,575	2,925 Added 25.69%	14,309 $649,000
Q2 2023 Aug 02, 2023	SELL	$43.47 - $67.77 $8,954 - $13,960	-206 Reduced 1.78%	11,384 $639,000
Q1 2023 May 03, 2023	SELL	$41.0 - $56.12 $14,678 - $20,090	-358 Reduced 3.0%	11,590 $524,000
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $4,820 - $8,077	-123 Reduced 1.02%	11,948 $485,000
Q3 2022 Dec 13, 2022	BUY	$61.1 - $83.78 $11,364 - $15,583	186 Added 1.56%	12,071 $789,000
Q2 2022 Aug 11, 2022	BUY	$43.23 - $73.83 $58,619 - $100,113	1,356 Added 12.88%	11,885 $722,000
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $99,252 - $147,861	1,866 Added 21.54%	10,529 $661,000
Q4 2021 Feb 11, 2022	BUY	$70.09 - $111.29 $97,915 - $155,472	1,397 Added 19.23%	8,663 $656,000
Q3 2021 Nov 01, 2021	BUY	$110.2 - $156.64 $800,713 - $1.14 Million	7,266 New	7,266 $813,000
Q3 2021 Oct 25, 2021	SELL	$110.2 - $156.64 $751,123 - $1.07 Million	-6,816 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$100.84 - $161.89 $38,117 - $61,194	378 Added 5.87%	6,816 $1.1 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $91,897 - $174,333	830 Added 14.8%	6,438 $784,000
Q4 2020 Jan 28, 2021	BUY	$79.67 - $173.23 $42,862 - $93,197	538 Added 10.61%	5,608 $859,000
Q3 2020 Nov 03, 2020	BUY	$78.5 - $100.64 $11,225 - $14,391	143 Added 2.9%	5,070 $424,000
Q2 2020 Jul 29, 2020	SELL	$38.5 - $76.05 $54,862 - $108,371	-1,425 Reduced 22.43%	4,927 $362,000
Q1 2020 Apr 17, 2020	BUY	$33.68 - $62.53 $57,963 - $107,614	1,721 Added 37.16%	6,352 $291,000
Q4 2019 Jan 13, 2020	BUY	$36.68 - $73.13 $169,865 - $338,665	4,631 New	4,631 $278,000
Q3 2011 Nov 14, 2022	BUY	N/A	186	12,071 $789,000

Others Institutions Holding CRSP

# of Institutions

485

Shares Held

57.5M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.24B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.

Account

Perigon Wealth Management, LLC Crispr Therapeutics Ag Transaction History